Syneos Health

Syneos Health is a multinational contract research organization (CRO) and contract commercial organization (CCO) that provides a broad range of clinical and commercial services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in helping its clients to accelerate the delivery of safe and effective therapies to the market.

History

Syneos Health was formed through the merger of INC Research and inVentiv Health in 2017. This strategic combination created an end-to-end service provider capable of offering a wide array of integrated biopharmaceutical solutions. The merger aimed to enhance the development and commercialization of new medical therapies by leveraging both companies' expertise in clinical development, commercialization, consulting, and communications.

Services

Syneos Health offers a comprehensive suite of services that span the entire lifecycle of a product, from early phase clinical trials to post-market commercialization. These services include but are not limited to:

• Clinical Development: Syneos Health conducts Phase I-IV clinical trials, providing expertise in trial design, patient recruitment, and regulatory affairs.
• Regulatory Affairs: The company assists with regulatory strategy, submission, and compliance, ensuring that products meet the necessary regulatory standards for approval.
• Commercialization: Syneos Health offers commercialization services, including brand strategy, market access, advertising, and patient engagement strategies.
• Consulting: Strategic consulting services are provided to address challenges in the biopharmaceutical industry, from portfolio management to market entry strategy.

Global Presence

With its headquarters in Morrisville, North Carolina, USA, Syneos Health operates in approximately 110 countries, employing over 24,000 professionals worldwide. The global reach of the company allows it to conduct large-scale international trials and provide localized commercial strategies.

Innovation and Technology

Syneos Health is committed to innovation in the biopharmaceutical services sector. The company invests in technology and data analytics to enhance clinical trial efficiency, improve patient recruitment, and deliver actionable insights for its clients. This includes the use of artificial intelligence and machine learning to predict trial outcomes and optimize study design.

Corporate Responsibility

Syneos Health is dedicated to operating responsibly, with a focus on sustainability, ethics, and social responsibility. The company's initiatives include environmental sustainability programs, ethical conduct in clinical trials, and community engagement efforts.

Challenges and Opportunities

As with any organization in the rapidly evolving biopharmaceutical industry, Syneos Health faces challenges such as regulatory changes, market competition, and the need for continuous innovation. However, the company's integrated service model, global footprint, and commitment to technology position it well to capitalize on the growing demand for outsourced clinical and commercial services.